HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
复制标题
西班牙高危人群中的丙型肝炎病毒抗体
DOI:
10.1016/s0140-6736(89)90485-6
复制
发表时间:
1989
期刊:
影响因子:
--
通讯作者:
G. Kuo
中科院分区:
文献类型:
--
作者:
J. Esteban;L. Viladomiu;António Gonzalez;M. Roget;J. Genescà;R. Esteban;J. López;Hernández Jm;V. Vargas;M. Buti;J. Guàrdia;M. Houghton;Q. Choo;G. Kuo
The frequency of hepatitis C virus (HCV) infection in Spain was assessed by means of a recombinant-based immunoassay for serum anti-HCV antibodies. 836 serum samples were tested from 676 patients selected according to their risk of blood-borne viral infections and presence of liver disease. Among patients at high risk of infection (with or without liver disease) anti-HCV antibodies were found in 85% of prospectively followed patients with post-transfusion non-A, non-B hepatitis, 62% of patients with chronic hepatitis or cirrhosis and a history of blood transfusion, 70% of haemophiliacs receiving replacement therapy, 70% of intravenous drug abusers, and 20% of haemodialysis patients. Only 8% of homosexual men infected with human immunodeficiency virus and 6% of female contacts of drug abusers were positive. Among patients with liver disease and no history of parenteral exposure to blood, anti-HCV antibodies were detected in 38% with cryptogenic, alcoholic, or primary biliary cirrhosis and in 44% with chronic active hepatitis. Among healthy subjects without risk factors for hepatitis the overall prevalence of anti-HCV was 1·2%.
影响因子:
6.4
作者:
ALTER, MJ;GERETY, RJ;MATANOSKI, GM
通讯作者:
MATANOSKI, GM